All-trans retinoic acid enhances bystander effect of suicide-gene therapy against medulloblastomas

Neuroscience Letters

Volumn 503, Issue 2, 2011, Pages 115-119

  Li, Shaoyi ^a   Gao, Yun ^a   Pu, Ke ^a   Ma, Li ^b   Song, Xiaofu ^a   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

All trans retinoic acid; Bystander effect; Herpes simplex virus thymidine kinase; Medulloblastoma; Neural stem cell

Indexed keywords

CONNEXIN 43; GANCICLOVIR; RETINOIC ACID; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BYSTANDER EFFECT; CELL CULTURE; CONTROLLED STUDY; DRUG POTENTIATION; HERPES SIMPLEX VIRUS; MALE; MEDULLOBLASTOMA; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE THERAPY;

ANIMALS; BYSTANDER EFFECT; CELL LINE; CEREBELLAR NEOPLASMS; CONNEXIN 43; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; HUMANS; ISOQUINOLINES; MALE; MEDULLOBLASTOMA; MICE; MICE, INBRED BALB C; SIMPLEXVIRUS; STIMULATION, CHEMICAL; THYMIDINE KINASE; TRETINOIN; UP-REGULATION;

EID: 80052959469     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.08.019     Document Type: Article

References (25)

1. Chen W., Yan C., Hou J., Pu J., Ouyang J., Wen D. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer. Urol. Oncol. 2008, 26(2008):397-405.
2. Dachs G.U., Hunt M.A., Syddall S., Singleton D.C., Patterson A.V. Bystander or no bystander for gene directed enzyme prodrug therapy. Molecules 2009, 14:4517-4545.
3. Huang Q., Liu X.Z., Kang C.S., Wang G.X., Zhong Y., Pu P.Y. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther. 2010, 17:192-202.
4. Ishii-Morita H., Agbaria R., Mullen C.A., Hirano H., Koeplin D.A., Ram Z., Oldfield E.H., Johns D.G., Blaese R.M. Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther. 1997, 4:244-251.
5. Jimenez T., Fox W.P., Naus C.C., Galipeau J., Belliveau D.J. Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy. Cell Commun. Adhes. 2006, 13:79-92.
6. Li S., Tokuyama T., Yamamoto J., Koide M., Yokota N., Namba H. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther. 2005, 12:600-607.
7. Li S., Tokuyama T., Yamamoto J., Koide M., Yokota N., Namba H. Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology 2005, 69:503-508.
8. Li S., Gao Y., Tokuyama T., Yamamoto J., Yokota N., Yamamoto S., Terakawa S., Kitagawa M., Namba H. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett. 2007, 251:220-227.
9. Matono S., Tanaka T., Sueyoshi S., Yamana H., Fujita H., Shirouzu K. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer. Int. J. Oncol. 2003, 23(2003):1309-1315.
10. Mehta P.P., Lokeshwar B.L., Schiller P.C., Bendix M.V., Ostenson R.C., Howard G.A., Roos B.A. Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP. Mol. Carcinog. 1996, 15:18-32.
11. Mesnil M., Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000, 60:3989-3999.
12. Mirza N., Fishman M., Fricke I., Dunn M., Neuger A.M., Frost T.J., Lush R.M., Antonia S., Gabrilovich D.I. All-trans retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 2006, 66:9299-9307.
13. Namba H., Tagawa M., Iwadate Y., Kimura M., Sueyoshi K., Sakiyama S. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells. Hum. Gene Ther. 1998, 9:5-11.
14. Namba H., Iwadate Y., Kawamura K., Sakiyama S., Tagawa M. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin 43 in the target cells. Cancer Gene Ther. 2001, 8:414-420.
15. Naus C.C., Bechberger J.F., Caveney S., Wilson J.X. Expressionof gap junction genes in astrocytes and C6 glioma cells. Neurosci. Lett. 1991, 126(1991):33-36.
16. Nicholas T.W., Read S.B., Burrows F.J., Kruse C.A. Suicide gene therapy with herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects. Histol. Histopathol. 2003, 18:495-507.
17. Packer R.G., Vezina G. Management of and prognosis with medulloblastoma: therapy at a crossroads. Arch. Neurol. 2008, 65:1419-1424.
18. Princen F., Robe P., Lechanteur C., Mesnil M., Rigo J.M., Gielen J., Merville M.P., Bours V. Cell type specific and gap junction independent mechanism for the HSV-tk/GCV mediated bystander effect. Clin. Cancer Res. 1999, 5:3639-3644.
19. Pu K., Li S.Y., Gao Y., Ma L., Ma W., Liu Y. Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression. Brain Res. 2011, 1369:245-252.
20. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 2000, 11:2389-2401.
21. Rossi A., Caracciolo V., Russo G., Reiss K., Giordano A. Medulloblastoma: from pathology to therapy. Clin. Cancer Res. 2008, 14:971-976.
22. Saez C.G., Velasquez L., Montoya M., Eugenín E., Alvarez M.G. Increased gap junctional intercellular communication is directly related to the anti-tumor effect of all-trans-retinoic acid plus tamoxifen in a human mammary cancer cell line. J. Cell. Biochem. 2003, 89:450-461.
23. Sanson M., Marcaud V., Robin E., Valéry C., Sturtz F., Zalc B. Connexin 43-mediated bystander effect in two rat glioma cell models. Cancer Gene Ther. 2002, 9:149-155.
24. Snyder E.Y., Deitcher D.L., Walsh C., Arnold-Aldea S., Hartwieg E.A., Cepko C.L. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992, 68:33-51.
25. Tanmahasamut P., Sidell N. Up-regulation of gap junctional intercellular communication and connexin 43 expression by retinoic acid in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 2005, 90:4151-4156.